Session Abstracts In

Total Page:16

File Type:pdf, Size:1020Kb

Session Abstracts In Natural Product Discovery and Development in the Genomic Era Sunday, January 21 12:00 PM - 6:00 PM Registration Grand Ballroom Foyer, lobby level 5:00 PM - 6:00 PM Keynote Speech: Nigel Mouncey, Director Joint Genome Institute "New Voyages to Explore the Natural Product Galaxy" Salons F-G, lobby level 6:00 PM - 7:00 PM Welcome Reception Salons A-E, lobby level 6:00 PM - 8:00 PM Session: PS1: Poster Session 1 Salons A-E, lobby level P1 Sonogashira diversification of unprotected halotryptophans, halotryptohan containing tripeptides; and generation of a new to nature bromo-natural product and its diversification in water C. Cartmell*, University of St. Andrews, Strathkinness, United Kingdom The blending together of synthetic chemistry and natural product biosynthesis provides a potentially powerful route to new natural product analogues2. Cystargamide is a structurally interesting lipo-depsi peptide containing a 5-hydroxy tryptophan as well as a 2, 3-epoxydecanoyl fatty acid chain3. We envisaged that by installing a sufficiently reactive handle (e.g. a C-Br bond) and developing compatible mild aqueous chemistries, biosynthesis of the halo-cystargamides and its subsequent chemical modification can be achieved. Precursor directed biosynthesis (PDB) provides a great potential for the production of new natural product analogues by exploiting the natural promiscuity of the enzymes involved in the biosynthesis of natural product. Using PDB method, we achieved the incorporation of various chloro/bromo-tryptophans and generated a series of halogenated analogues of cystargamide. 6- Br-cystargamide was subsequently diversified using aqueous cross coupling chemistries such as the Sonogashira reaction to obtain new derivatives of cystargamide. The installation of bromo/chloro handle also provided an excellent analytical handle for investigation of all metabolites by LC-MS/MS. With knowledge gained from the fragmentation of the natural cystargamide, we analysed the MSn data to identify and characterise the new natural products analogues produced via the Sonogashira reaction1. References 1. J. Corr, S. V. Sharma, C. Pubill-Ulldemolins, et al. Chem Sci., 8, 2039-2046, (2017) P3 Identification and functional analysis of the aspergillic acid gene cluster in Aspergillus flavus M. Lebar*, J. Cary, R. Majumdar, C. Carter-Wientjes, B. Mack and Q. Wei, USDA, New Orleans, LA, USA; V. Uka, University of Ghent, Ghent, Belgium; S. DeSaeger, University of Ghent, Gent, Belgium; J. Di Mavungu, University of Gent, Gent, Belgium Aspergillus flavus can colonize important food staples and produce aflatoxins, a group of toxic and carcinogenic secondary metabolites. In silico analysis of the A. flavus genome has revealed 56 gene clusters predicted to be involved in the biosynthesis of secondary metabolites. A. flavus secondary metabolites produced during infection of maize seed are of particular interest, especially with respect to their roles in the biology of the fungus. A predicted nonribosomal peptide synthetase-like (NRPS-like) gene, designated asaC (AFLA_023020), present in the uncharacterized A. flavus secondary metabolite gene cluster 11 was shown to be expressed during the earliest stages of maize kernel infection. Cluster 11 was shown to be composed of six additional genes encoding a number of putative decorating enzymes as well as a transporter and transcription factor. LC-MS analysis of extracts from knockout mutants of these genes showed that they were responsible for the synthesis of the previously characterized antimicrobial mycotoxin aspergillic acid. Extracts of the asaC mutant showed no production of aspergillic acid or its precursors. Knockout of the cluster P450 oxidoreductase afforded a pyrazinone metabolite, the aspergillic acid precursor deoxyaspergillic acid. The hydroxamic acid functional group in aspergillic acid allows the molecule to bind to iron resulting in the production of a red pigment in A. flavus previously identified as ferriaspergillin. We observed significantly less fungal growth on maize kernels infected with A. flavus ΔasaC compared to A. flavus control and are currently investigating the role aspergillic acid plays in maize kernel infection, possibly through iron sequestration. P5 Photoprotection of the potent polyene antibiotic Marinomycin C. Bailey*, J. Zarins-Tutt, M. Agbo, M. Gan, E. Abraham, R. Hamed and R. Goss, University of St Andrews, St Andrews, United Kingdom; A.D. Taboada and G. Mackenzie, Sporomex Ltd, Bridlington, United Kingdom; A. Evans, Queen's University, Kingston, ON, Canada Bioactive polyenes are abundant in nature showing a broad range of chemical diversity and biological activities. Despite the promising bioactivity of many isolated polyenes, the inherent instability of polyene systems towards photoisomerization continues to deter their development towards potential lead drug candidates. Marinomycin is a particularly noteworthy, but photolabile, polyene antibiotic with excellent activity against MRSA and VRSA.1 We envisaged that microencapsulating polyenes using a chemically inert, biocompatible, non-toxic natural polymers could be utilised to improve photostability and as a drug carrier. We have demonstrated a striking level of photoprotection (t1/2 extended from 8 seconds – 34 minutes, when exposed directly to 312 nm UV radiation at 48 W) using a natural biopolymer. Our results show promise for the clinical development and administration of polyenes, such as marinomycin, that would otherwise be too unstable to consider. Additionally a serendipitous discovery revealed that our biopolymer could be used to selectively extract culture broths containing marinomycin providing higher recovery than extraction with conventional XAD resins. References H. C. Kwon, C. A. Kauffman, P. R. Jensen and W. Fenical, J. Am. Chem. Soc., 2006, 128, 1622–1632. P7 Biochemical role of multicore precursor peptides in a RiPP pathway W. Gu*, D. Sardar and E. Schmidt, University of Utah, Salt Lake City, UT, USA Cyanobactin pathways are diversity-generating biosynthetic pathways that can process hypervariable substrates. Each cyanobactin precursor peptide contains multiple core sequences encoding different natural products, which is not common in RiPPs. The role of these multicore precursor peptides remains unclear. Preliminary in vivo data suggests that the cassette position influences the production yield. Here, we perform biochemical experiments that define the role of multiple cassettes in cyanobactin RiPP biosynthesis. Investigation of the mechanisms behind this recognition will help us better control cyanobactin production for potential therapeutic applications. P9 Biosynthetic and genome mining approaches to identify triazine containing natural products K. Almabruk* and B. Philmus, Oregon State University, Corvallis, OR, USA; M. Fenwick and S. Ealick, Cornell University, Ithaca, NY, USA Triazine containing natural products are of interest because of their attractive biological activities and the unique chemistry involved in their biosynthesis. One of the most studied examples is toxoflavin, which has been isolated from plant pathogenic strains of Burkholderia, and plays a key role in virulence. Genome mining has revealed that triazine natural product gene clusters are found in pseudomonads and actinobacteria suggesting that triazine-containing natural products are more prevalent than previously realized. In this study, we present our results from precursor labeling studies in an effort to shed light on the complex biosynthetic steps involved in forming the N-N-bond of the triazine moiety during toxoflavin biosynthesis. We also discuss the crystallographic and the in vitro characterization of two N- methyltransferases that use 1,6-didesmethyltoxoflavin (1,6-DDMT) as a substrate. P11 Metagenomics-guided natural product discovery and engineering in bacteria T. Shock, X. Yang*, D. Chandran, J. Shock, O. Liu and J. Kim, Radiant Genomics, Emeryville, CA, USA Metagenomics continues to play an increasingly important role in the discovery of natural products. With the combination of next-generation sequencing, bioinformatics, genetic engineering and natural product chemistry, previously-inaccessible chemical diversity in our environment are being gradually uncovered. These technologies also circumvent the constraints of traditional culture-based natural product discovery, allowing for targeted approaches in heterologous hosts. This work focuses on recent progress in pipeline development and process engineering in a startup-scale industrial setting. P13 Autometa: Automated extraction of microbial genomes from shotgun metagenomes I. Miller*, E. Rees, J. Ross, I. Miller, J. Baxa, J. Lopera, R. Kerby, F. Rey and J. Kwan, University of Wisconsin - Madison, Madison, WI, USA Culture-independent sequencing (metagenomics) is a powerful, high resolution technique enabling the study of microbial communities in situ. With modern sequencing technology and bioinformatics, individual genomes can be assembled and extracted directly from environmental samples containing complex microbial communities by a process known as metagenomic "binning." However, available binning programs suffer from methodological and practical shortcomings, such as the requirement of human pattern recognition, which is inherently unscalable, low-throughput, and poorly reproducible. Some methods also require the assembly of pooled samples, which can lead to poor assemblies in the case of inter-sample strain variability. We therefore devised a fully-automated pipeline,
Recommended publications
  • (12) United States Patent (10) Patent No.: US 7,879,798 B1 Aufseeser (45) Date of Patent: Feb
    US007879798B1 (12) United States Patent (10) Patent No.: US 7,879,798 B1 Aufseeser (45) Date of Patent: Feb. 1, 2011 (54) COMPOSITION FOR INDOLENT WOUND Mazzotta, M.Y. “Nutrition and Wound Healing.” J. Am. Podiatr. Med. HEALING AND METHODS OF USE Assoc. 84(9): 456-462, Sep. 1994. THEREFOR Niedermeier, S. "Tierexperimentelle Untersuchungen Zur Frage der Behandlung von Hornhautlasionen Animal experiment studies on the problem of treating corneal lesions.” Klin. Monatsbl. (75) Inventor: Leslie S. Aufseeser, Lakewood, NJ (US) Augenheilkd (Germany, West), 190 (1):28-9, Jan. 1987. Seifter, E. etal. “Impaired Wound Healing in Streptozotocin diabetes. (73) Assignee: Regenicel, Inc., Lakewood, NJ (US) Prevention by supplemental Vitamin A.” Ann. Surgery (US). 194(1): 42-50, Jul. 1981. (*) Notice: Subject to any disclaimer, the term of this Gilmore, O.J.A. etal. “Aetiology and prevention of wound infection patent is extended or adjusted under 35 in appendicetomy.” British Journal of Surgery, 61:281-287. Mar. U.S.C. 154(b) by 594 days. 1974. Lowenfels, Albert B. “Viewpoints: Wound Healing With No Oint (21) Appl. No.: 11/895,474 ment, Non-antibiotic Ointment, or Antibiotic Ointment”. Medscape General Surgery. 8(2), 2006. (22) Filed: Aug. 24, 2007 United States Food and Drug Administration. “First Aid Antibiotic Drug Products”. Code of Federal Regulations, Title 21, vol. 5, Chap (51) Int. Cl. ter I, Part 333, Subpart B, pp. 222-225, Apr. 1, 2006. A6 IK 38/12 (2006.01) Akpek, EK et al. "A randomized trial of low-dose, topical mitomycin-C in the treatment of severe vernal keratoconjunctivitis.” (52) U.S.
    [Show full text]
  • Poster Session 1 Natural Product Discovery and Development in The
    Session Poster Session 1 Natural Product Discovery and Development in the Genomic Era Paper Sonogashira diversification of unprotected halotryptophans, halotryptohan containing tripeptides; and generation of a new to nature bromo-natural product and its diversification in water Chris Cartmell, University of St. Andrews, Strathkinness, United Kingdom Natural Product Discovery and Development in the Genomic Era The blending together of synthetic chemistry and natural product biosynthesis provides a potentially powerful route to new natural product analogues2. Cystargamide is a structurally interesting lipo-depsi peptide containing a 5-hydroxy tryptophan as well as a 2, 3-epoxydecanoyl fatty acid chain3. We envisaged that by installing a sufficiently reactive handle (e.g. a C-Br bond) and developing compatible mild aqueous chemistries, biosynthesis of the halo-cystargamides and its subsequent chemical modification can be achieved. Precursor directed biosynthesis (PDB) provides a great potential for the production of new natural product analogues by exploiting the natural promiscuity of the enzymes involved in the biosynthesis of natural product. Using PDB method, we achieved the incorporation of various chloro/bromo-tryptophans and generated a series of halogenated analogues of cystargamide. 6-Br-cystargamide was subsequently diversified using aqueous cross coupling chemistries such as the Sonogashira reaction to obtain new derivatives of cystargamide. The installation of bromo/chloro handle also provided an excellent analytical handle for investigation of all metabolites by LC-MS/MS. With knowledge gained from the fragmentation of the natural cystargamide, we analysed the MSn data to identify and characterise the new natural products analogues produced via the Sonogashira reaction1. References 1. J. Corr, S.
    [Show full text]
  • From Sugar Based Bio Renewable Resources to New Chemical Building Blocks and Bioactive Molecules
    Raquel Alexandra Germano Nunes Licenciatura em Química Aplicada From sugar based bio renewable resources to new chemical building blocks and bioactive molecules Dissertação para obtenção do Grau de Mestre em Química Bioorgânica Orientador: Prof. Doutor Carlos Alberto Mateus Afonso, FF-UL Co-orientador: Rafael Filipe Teixeira Arbuéz Gomes, MSc, FF-UL Presidente: Prof. Doutora Paula Cristina de Sério Branco, FCT-UNL Arguente: Prof. Doutora Luísa Maria da Silva Pinto Ferreira, FCT-UNL Vogal: Prof. Doutor Carlos Alberto Mateus Afonso, FF-UL Março 2017 LOMBADA Raquel Nunes Raquel From sugar based bio renewable resources to new chemical building blocks and bioactive molecules bioactive and blocks chemical new building to resources renewable bio based sugar From 2017 Raquel Alexandra Germano Nunes Licenciatura em Química Aplicada From sugar based bio renewable resources to new chemical building blocks and bioactive molecules Dissertação para obtenção do Grau de Mestre em Química Bioorgânica Orientador: Prof. Doutor Carlos Alberto Mateus Afonso, FF-UL Co-orientador: Rafael Filipe Teixeira Arbuéz Gomes, MSc, FF-UL Presidente: Prof. Doutora Paula Cristina de Sério Branco, FCT-UNL Arguente: Prof. Doutora Luísa Maria da Silva Pinto Ferreira, FCT-UNL Vogal: Prof. Doutor Carlos Alberto Mateus Afonso, FF-UL Março 2017 From sugar based bio renewable resources to new chemical building blocks and bioactive molecules Copyright © Raquel Alexandra Germano Nunes, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa. A Faculdade de Ciências e Tecnologia e a Universidade Nova de Lisboa têm o direito, perpétuo e sem limites geográficos, de arquivar e publicar esta dissertação através de exemplares impressos reproduzidos em papel ou de forma digital, ou por outro qualquer meio conhecido ou que venha a ser inventado e de divulgar através de repositórios científicos e de admitir a sua cópia e distribuição com objectivos educacionais ou de investigação, não comerciais, desde que seja dado crédito ao autor e editor.
    [Show full text]
  • Antibiotic Discovery
    ANTIBIOTIC DISCOVERY RESISTANCE PROFILING OF MICROBIAL GENOMES TO REVEAL NOVEL ANTIBIOTIC NATURAL PRODUCTS By CHELSEA WALKER, H. BSc. A Thesis Submitted to the School of Graduate Studies in Partial Fulfilment of the Requirements for the Degree Master of Science McMaster University © Copyright by Chelsea Walker, May 2017 McMaster University MASTER OF SCIENCE (2017) Hamilton, Ontario (Biochemistry and Biomedical Sciences) TITLE: Resistance Profiling of Microbial Genomes to Reveal Novel Antibiotic Natural Products. AUTHOR: Chelsea Walker, H. BSc. (McMaster University) SUPERVISOR: Dr. Nathan A. Magarvey. COMMITTEE MEMBERS: Dr. Eric Brown and Dr. Michael G. Surette. NUMBER OF PAGES: xvii, 168 ii Lay Abstract It would be hard to imagine a world where we could no longer use the antibiotics we are routinely being prescribed for common bacterial infections. Currently, we are in an era where this thought could become a reality. Although we have been able to discover antibiotics in the past from soil dwelling microbes, this approach to discovery is being constantly challenged. At the same time, the bacteria are getting smarter in their ways to evade antibiotics, in the form of resistance, or self-protection mechanisms. As such is it essential to devise methods which can predict the potential for resistance to the antibiotics we use early in the discovery and isolation process. By using what we have learned in the past about how bacteria protect themselves for antibiotics, we can to stay one step ahead of them as we continue to search for new sources of antibiotics from bacteria. iii Abstract Microbial natural products have been an invaluable resource for providing clinically relevant therapeutics for almost a century, including most of the commonly used antibiotics that are still in medical use today.
    [Show full text]
  • Anew Drug Design Strategy in the Liht of Molecular Hybridization Concept
    www.ijcrt.org © 2020 IJCRT | Volume 8, Issue 12 December 2020 | ISSN: 2320-2882 “Drug Design strategy and chemical process maximization in the light of Molecular Hybridization Concept.” Subhasis Basu, Ph D Registration No: VB 1198 of 2018-2019. Department Of Chemistry, Visva-Bharati University A Draft Thesis is submitted for the partial fulfilment of PhD in Chemistry Thesis/Degree proceeding. DECLARATION I Certify that a. The Work contained in this thesis is original and has been done by me under the guidance of my supervisor. b. The work has not been submitted to any other Institute for any degree or diploma. c. I have followed the guidelines provided by the Institute in preparing the thesis. d. I have conformed to the norms and guidelines given in the Ethical Code of Conduct of the Institute. e. Whenever I have used materials (data, theoretical analysis, figures and text) from other sources, I have given due credit to them by citing them in the text of the thesis and giving their details in the references. Further, I have taken permission from the copyright owners of the sources, whenever necessary. IJCRT2012039 International Journal of Creative Research Thoughts (IJCRT) www.ijcrt.org 284 www.ijcrt.org © 2020 IJCRT | Volume 8, Issue 12 December 2020 | ISSN: 2320-2882 f. Whenever I have quoted written materials from other sources I have put them under quotation marks and given due credit to the sources by citing them and giving required details in the references. (Subhasis Basu) ACKNOWLEDGEMENT This preface is to extend an appreciation to all those individuals who with their generous co- operation guided us in every aspect to make this design and drawing successful.
    [Show full text]
  • Discovery of Phosphonic Acid Natural Products by Mining the Genomes of 10,000 Actinomycetes
    Discovery of phosphonic acid natural products by mining the genomes of 10,000 actinomycetes Kou-San Jua, Jiangtao Gaoa, James R. Doroghazia, Kwo-Kwang A. Wanga, Christopher J. Thibodeauxa, Steven Lia, Emily Metzgera, John Fudalaa, Joleen Sua, Jun Kai Zhanga,b, Jaeheon Leea, Joel P. Cionia,b, Bradley S. Evansa, Ryuichi Hirotaa,c, David P. Labedad, Wilfred A. van der Donka,e,1, and William W. Metcalfa,b,1 aCarl R. Woese Institute for Genomic Biology, University of Illinois, Urbana, IL 61801; bDepartment of Microbiology, University of Illinois, Urbana, IL 61801; cDepartment of Molecular Biotechnology, Graduate School of Advanced Sciences of Matter, Hiroshima University, 1-3-1 Kagamiyama, Higashi-Hiroshima, Hiroshima 739-8530, Japan; dBacterial Foodborne Pathogens and Mycology Research, US Department of Agriculture, Agricultural Research Service, National Center for Agricultural Utilization Research, Peoria, IL 61604; and eDepartment of Chemistry and Howard Hughes Medical Institute, University of Illinois, Urbana, IL 61081 Edited by Jerrold Meinwald, Cornell University, Ithaca, NY, and approved July 31, 2015 (received for review January 14, 2015) Although natural products have been a particularly rich source of generally adopted. If we hope to revitalize the use of natural human medicines, activity-based screening results in a very high products in the pharmaceutical industry, genome mining must be rate of rediscovery of known molecules. Based on the large number shown to be a high-throughput discovery process complementary of natural product biosynthetic genes in microbial genomes, many or superior to existing methods (13, 14). Here, we demonstrate the have proposed “genome mining” as an alternative approach for feasibility of this approach in a campaign to identify the full ge- discovery efforts; however, this idea has yet to be performed ex- netic repertoire of phosphonic acid natural products encoded by a perimentally on a large scale.
    [Show full text]
  • Microbial Lactam Biosynthesis and Biosensing by Jingwei Zhang a Dissertation Submitted in Partial Satisfaction of the Requiremen
    Microbial Lactam Biosynthesis and Biosensing by Jingwei Zhang A dissertation submitted in partial satisfaction of the requirements for the degree of Joint Doctor of Philosophy with University of California, San Francisco in Bioengineering in the Graduate Division of the University of California, Berkeley Committee in charge: Professor Jay Keasling, Chair Professor John Dueber Professor Shawn Douglas Professor Wenjun Zhang Fall 2015 Microbial Lactam Biosynthesis and Biosensing Copyright 2015 by Jingwei Zhang Abstract Microbial Lactam Biosynthesis and Biosensing by Jingwei Zhang Joint Doctor of Philosophy with University of California, San Francisco in Bioengineering University of California, Berkeley Professor Jay D. Keasling, Chair Lactam is an important class of commodity chemicals used in the manufacture of nylons, with millions of tons of production every year. 2-Pyrrolidone is a valuable bulk chemical with myriad applications as a solvent, polymer precursor and active pharmaceutical intermediate. A novel 2-pyrrolidone synthase, ORF27, from Streptomyces aizunensis was identified to catalyze the ring closing dehydration of γ- aminobutyrate. ORF27’s tendency to aggregate was resolved by expression at low temperature and fusion to the maltose binding protein (MBP). Recombinant Escherichia coli was metabolically engineered for the production of 2-pyrrolidone from glutamate by expressing both the genes encoding GadB, a glutamate decarboxylase, and ORF27. Incorporation of a GadB mutant lacking H465 and T466, GadB_ΔHT, improved the efficiency of one-pot 2-pyrrolidone biosynthesis in vivo. When the recombinant E. coli strain expressing the E. coli GadB_ΔHT mutant and the ORF27-MBP fusion was cultured in ZYM-5052 medium containing 9 g/L of L- glutamate, 7.7 g/L of L-glutamate was converted to 1.1 g/L of 2-pyrrolidone within 31 h, achieving 25% molar yield from the consumed substrate.
    [Show full text]
  • Substance Index for Volume 66
    The Journal of Antibiotics (2013) 66, 749–753 & 2013 Japan Antibiotics Research Association All rights reserved 0021-8820/13 www.nature.com/ja Substance Index for Volume 66 (3R,4R)-4-Acetoxy-3-[(R)-1-(t-butyldimethylsilyloxy) 161 A26771B 123 ethyl]-2-azetidinone AB3217-A 123 4-O-(400-O-Acetyl-a-L-rhamnopyranosyl)-ellagic acid 123 Acidomycin 371 Bedaquiline 571 Aclacinomycin A, N-benzyl- 165 4-O-Benzoyl-2,3,6-trideoxy-3-C-methyl-3- 131 Actinopyrone A 123 trifluoroacetamido-a,b-L-lyxo-hexopyranosyl acetate Actinorhodin 387 4-O-Benzyl-2,3,6-trideoxy-3-C-methyl-3-azido-a,b-L-lyxo- 131 Actinorhodin, diepoxy 295 hexopyranosyl acetate AFN-1252 571 4-O-Benzyl-2,3,6-trideoxy-3-C-methyl-3- 131 Albaflavenone 387 trifluoroacetamido-a,b-L-lyxo-hexopyranosyl acetate Albocycline 303 (S, Z)-3-Benzylidene-6-isopropylpiperazine-2,5-dione 31 Allosamizoline 123 (S, Z)-3-Benzylidene-6-methylpiperazine-2,5-dione 31 N-Allyl-aclacinomycin A 165 3-Benzylpiperazine-6-(4-methoxybenzylidene)-2,5-dione 31 (4R*,6R*,8S*)-8-Allyl-9,9-dimethyl-1-methoxy-4- 141 Bhimamycin F, H, I 719 prenyl-6-((triisopropylsilyloxy)methyl)bicyclo Biapenem 571 [3.3.1]non-1-ene-3,5-dione Biemodin 491 (4S*,6R*,8S*)-3-(8-Allyl-9,9-dimethyl-1-methoxy-6- 141 Brartemicin analogs 531 ((triisopropylsilyloxy)methyl)bicyclo[3.3.1]non-1- Brilacidin 571 ene-3,5-dione-4-yl)methyl)-2,2-dimethyloxirane (3S)-4-Bromo-2,3-dimethylbut-1-ene 147 (4S*,6R*,8S*,18S*)-8-Allyl-18-(1-hydroxy-1-methylethyl) 141 (2E,5R)-1-tert-Butyldiphenylsilyloxy-5- 155 -9,9-dimethyl-6-((triisopropylsilyloxy)methyl)-31- methanesulfonyloxy-2-methylhex-2-ene
    [Show full text]
  • Taxonomic Characterization and Secondary Metabolite Analysis of NEAU-Wh3-1: an Embleya Strain with Antitumor and Antibacterial Activity
    microorganisms Article Taxonomic Characterization and Secondary Metabolite Analysis of NEAU-wh3-1: An Embleya Strain with Antitumor and Antibacterial Activity 1, 1, 1 1 1 1 1,2, Han Wang y, Tianyu Sun y, Wenshuai Song , Xiaowei Guo , Peng Cao , Xi Xu , Yue Shen * and Junwei Zhao 1,* 1 Key Laboratory of Agricultural Microbiology of Heilongjiang Province, Northeast Agricultural University, No. 600 Changjiang Road, Xiangfang District, Harbin 150030, China; [email protected] (H.W.); [email protected] (T.S.); [email protected] (W.S.); [email protected] (X.G.); [email protected] (P.C.); [email protected] (X.X.) 2 College of Science, Northeast Agricultural University, No. 600 Changjiang Road, Xiangfang District, Harbin 150030, China * Correspondence: [email protected] (Y.S.); [email protected] (J.Z.) These authors contributed equally to this work. y Received: 28 February 2020; Accepted: 18 March 2020; Published: 20 March 2020 Abstract: Cancer is a serious threat to human health. With the increasing resistance to known drugs, it is still urgent to find new drugs or pro-drugs with anti-tumor effects. Natural products produced by microorganisms have played an important role in the history of drug discovery, particularly in the anticancer and anti-infective areas. The plant rhizosphere ecosystem is a rich resource for the discovery of actinomycetes with potential applications in pharmaceutical science, especially Streptomyces. We screened Streptomyces-like strains from the rhizosphere soil of wheat (Triticum aestivum L.) in Hebei province, China, and thirty-nine strains were obtained. Among them, the extracts of 14 isolates inhibited the growth of colon tumor cell line HCT-116.
    [Show full text]
  • Metabolomics and Chemical Library Screening for Antibacterial
    METABOLOMICS AND CHEMICAL LIBRARY SCREENING FOR ANTIBACTERIAL DRUG DISCOVERY A DISSERTATION IN Pharmaceutical Sciences and Chemistry Presented to the Faculty of University of Missouri-Kansas City in partial fulfillment of the requirements for the degree DOCTOR OF PHILOSOPHY By NAVID JUBAER AYON MS, University of Missouri-Kansas City, 2019 MPharm, University of Dhaka, 2013 BPharm, University of Dhaka, 2012 Kansas City, Missouri, USA 2020 © 2020 NAVID JUBAER AYON ALL RIGHTS RESERVED ii METABOLOMICS AND CHEMICAL LIBRARY SCREENING FOR ANTIBACTERIAL DRUG DISCOVERY Navid Jubaer Ayon, Candidate for the Doctor of Philosophy Degree University of Missouri–Kansas City, 2020 ABSTRACT There are twenty standard amino acids which are proteinogenic and can exist in two stereoisomeric forms, D- and L-enantiomers, except for glycine, which is achiral. The D-amino acids are not incorporated in proteins; however, they play important roles in many biological systems and processes. Amino acids are polar analytes and are difficult to separate on traditional silica based stationary phases in reverse phase chromatography to allow accurate quantification in their natural form. In part I of this dissertation, we investigated the use of a chiral derivatizing reagent known as Marfey’s reagent, coupled with liquid chromatography tandem mass spectrometry (LC-MS/MS) based separation and quantification for the common proteinogenic amino acid D- and L- stereoisomers. We compared standard formic acid and ammonium acetate based solvent systems in both positive and negative modes; and established baseline separation with superior sensitivity for all nineteen amino acid pairs and glycine with an analytical C8 column in reverse phase chromatography in negative ionization mode using an ammonium acetate based neutral solvent system.
    [Show full text]
  • Genome and Metagenome Mining Reveals Unexpected Environmental Distribution of Abyssomicins
    Supporting Information Out of the abyss: Genome and metagenome mining reveals unexpected environmental distribution of abyssomicins Alba Iglesias1, Adriel Latorre‐Pérez2, James E. M. Stach3, Manuel Porcar2,4, Javier Pascual2 1 School of Biology, Devonshire Building, Newcastle University, Newcastle, United Kingdom. 2 Darwin Bioprospecting Excellence SL, Paterna, Spain. 3 School of Biology, Ridley Building, Newcastle University, Newcastle, United Kingdom; Centre for Synthetic Biology and the Bioeconomy, Baddiley-Clark Building, Newcastle University, Newcastle, United Kingdom. 4 Institute for Integrative Systems Biology (I2SysBio), University of Valencia-CSIC, Paterna, Spain. Corresponding author: [email protected] Contents Page Figure S1. Habitat distribution of the metagenomes analysed for the presence of AbyU, AbmU and AbsU. 2 Figure S2. Taxonomic profile at the phylum level of ten marine (1-10), ten terrestrial (11-20) and ten Diels- Alderase positive (21-30) metagenomes. These metagenomes were randomly selected from the 3027 metagenomes analysed. The ten Diels-Alderase positive were six terrestrial (21-26), one 3 Arthropoda-associated (27) and three plant-associated (28-30). Only the most abundant phyla are shown. Numbers above each bar plot indicate metagenome size (Mb). Figure S3. Taxonomic profile at the order level of ten marine (1-10), ten terrestrial (11-20) and ten Diels- Alderase positive (21-30) metagenomes. These metagenomes were randomly selected from the 4 3027 metagenomes analysed. The ten Diels-Alderase positive were six terrestrial (21-26), one Arthropoda-associated (27) and three plant-associated (28-30). Figure S4. Habitat distribution of the Diels-Alderase positive isolates found by genome mining. 5 Figure S5. Habitat distribution of the Diels-Alderase positive isolates found by genome mining to have an 6 abyssomicin or potential abyssomicin BGC (both total and partial).
    [Show full text]
  • WO 2015/017866 Al 5 February 2015 (05.02.2015) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2015/017866 Al 5 February 2015 (05.02.2015) P O P C T (51) International Patent Classification: Gregory, B. [US/US]; C/o 83 Cambridge Parkway, Cam C12N 15/63 (2006.01) C40B 40/06 (2006.01) bridge, MA 02142 (US). C12N 15/87 (2006.01) (74) Agents: ALTIERI, Stephen, L. et al; Bingham Mc- (21) International Application Number: cutchen LLP, 2020 K Street, NW, Washington, DC 20006- PCT/US20 14/049649 1806 (US). (22) International Filing Date: (81) Designated States (unless otherwise indicated, for every 4 August 2014 (04.08.2014) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (25) Filing Language: English BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (26) Publication Language: English DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, (30) Priority Data: KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, 61/861,805 2 August 2013 (02.08.2013) US MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, 61/883,13 1 26 September 2013 (26.09.2013) US OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, 61/935,265 3 February 2014 (03.02.2014) US SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, 61/938,933 12 February 2014 (12.02.2014) US TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (71) Applicant: ENEVOLV, INC.
    [Show full text]